Clinicians in the U.K. will now be able to prescribe the antifibrotic medicine Ofev (nintedanib) to people with non-idiopathic…
Articles by Steve Bryson, PhD
An open inspection issue at a third-party testing facility has put on hold …
Research examining the role that protein-RNA interactions play in promoting pulmonary fibrosis (PF) and other related conditions is being…
A single dose of the investigational oral therapy PLN-74809 for idiopathic pulmonary fibrosis (IPF) achieved therapeutic target engagement…
TXR-1002 and TXR-1007, two new therapeutic candidates for idiopathic pulmonary fibrosis (IPF) from Aria Pharmaceuticals, demonstrated significant efficacy at…
People with idiopathic pulmonary fibrosis (IPF) infected with SARS-CoV-2, the virus that causes COVID-19, are at a greater risk…
The degree of collagen degradation, a process called collagen turnover, evident in a person’s blood at the time idiopathic pulmonary…
A subset of fibroblasts that produce a protein called meflin in lung tissues taken from people with idiopathic pulmonary…
Changes in gene activity and immune cell populations in the lungs of people with chronic lung diseases, such as…
Enrollment has resumed, under a revised trial protocol, in the Phase 2b study GALACTIC-1, which is evaluating Galecto’s investigational inhaled…